Analystreport

Celyad Oncology SA (NASDAQ: CYAD) had its "hold" rating re-affirmed by analysts at Jonestrading.

Celyad Oncology SA - American Depositary Shares  (CYAD) 
US:NASDAQ Investor Relations: celyad.com/en/investors